PATENT CLAIM ANALYSIS

Application Number: 16056676
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["607", "004000"]

Abstract:
An implantable medical device system includes a pacemaker and an implantable cardioverter defibrillator (ICD). The pacemaker is configured to confirm a hemodynamically unstable rhythm based on an activity metric determined from an activity sensor signal after detecting a ventricular tachyarrhythmia and withhold anti-tachycardia pacing (ATP) pulses in response to confirming the hemodynamically unstable rhythm. The pacemaker may deliver ATP when a hemodynamically unstable rhythm is not confirmed based on the activity metric. The ICD is configured to detect the ATP and withhold a shock therapy in response to detecting the ATP in some examples.

Claim (Index 8):
The method of  claim 7 , wherein:\n determining the absence of ATP pulses comprises monitoring for at least one ATP pulse during a shock delay interval; and delivering the shock therapy comprises delivering the shock therapy after expiration of the shock delay interval in response to determining the absence of ATP pulses during the shock delay interval.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 1.85455
- Patent Class: 607.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14657001', '14823405', '13569208', '14687010', '11382120']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7527910465055456
- 35 USC 102 Novelty (BERT): 0.6201167288414844
- Combined Prediction Score: 0.7395236147391395
- Mean Citation Score: 429.102552
- Max Citation Score: 635.3974599999998
- Similarity Product: 507.7971510306989

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test